Developing state-of-the art molecular genetic testing in cancer diagnosis and monitoring
New prognostic score for Follicular Lymphoma to rationalise therapeutic decision-making and improve patient outcomes
Deep profiling of ALL and myeloma for targeted therapies
Understanding the process of progression from MDS to acute leukaemia
Characterisation of a novel DCAF factor as a blood cancer therapy
Precision Medicine in acute lymphoblastic leukaemia
The Centre for Blood Transplant and Cell Therapy
The role of the bone marrow microenvironment in the myeloma plasma cell dormancy and reactivation
